Summary
The clinical genetics of genetic generalized epilepsy suggests complex inheritance; large pedigrees, with multiple affected individuals, are rare exceptions. We studied a large consanguineous family from Turkey where extensive electroclinical phenotyping revealed a familial phenotype most closely resembling juvenile myoclonic epilepsy. For a subject to be considered affected (n = 14), a diagnostic electroencephalogram was required. Seizure onset ranged between 6 and 19 years (mean = 12 years). Thirteen of 14 experienced myoclonic jerks; in 11, this was associated with eyelid blinking, and in 10 it was interspersed with absences. Generalized tonic-clonic seizures were seen in 11. One individual had generalized tonicclonic seizures alone. Electroencephalograms demonstrated generalized polyspike and wave discharges that were not associated with photoparoxysmal response.
Intellect was normal. Nineteen family members were subsequently chosen for nonparametric multipoint linkage analyses, which identified a 39.5 Mb region on chromosome 5 (P < 0.0001). Iterative analysis, including discovery of a subtly affected individual, narrowed the critical region to 15.4 Mb and possibly to 5.5 Mb. Homozygous versus heterozygous state of the refined 5p13.2-q11.1 haplotype was not associated with phenotypic severity or onset age, suggesting that one versus two pathogenic variants may result in similar phenotypes. Whole exome sequencing (n = 3) failed to detect any rare, protein-coding variants within the highly significant linkage region that includes HCN1 as a promising candidate.
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| INTRODUCTION
The genetic generalized epilepsies (GGEs) are among of the commonest forms of epilepsy. Evidence for their genetic etiology is a recurrence risk ratio of 4-9 compared to the general population and very high concordance in monozygotic twins. 1 These data, together with pedigree analyses, suggest most cases are due to complex inheritance, involving two or more genes. Consistent with this, recurrent copy number variants (CNVs) at 15q13. 1 The advent of next generation sequencing, initially via whole exome sequencing, and now more increasingly by whole genome sequencing, has led to the expeditious discovery of many of the underlying causal variants in linkage regions. 6 As such, large kinships with multiple affected family members and a Mendelian inheritance pattern may facilitate gene discovery in rare GGEs.
To further understand the genetic architecture of GGE, we studied a large family from southeastern Turkey with a pedigree suggestive of Mendelian inheritance and report the linkage analysis.
| MATERIALS AND METHODS

| Patients
The proband and his available family members underwent a detailed clinical interview by telephone and in person. The study involved neurological examination and a 3-hour 21-channel electroencephalographic (EEG) recording, which included hyperventilation and intermittent photic stimulation. Medical records were also collected.
Diagnoses were made in accordance with the International League Against Epilepsy classification and terminology 7, 8 ; for an individual to be considered affected, a diagnostic EEG was required. The study was approved by Istanbul University's institutional review board and by the Human Research Ethics Committee, Austin Health. All participating patients and family members gave informed consent.
| Molecular genetic analysis
DNA was obtained from as many family members as possible (Appendix S1, Methods). Nineteen family members (14 affected and five unaffected) were chosen for single nucleotide polymorphism (SNP) genotyping using the Illumina Infinium HumanOmniExpress BeadChip microarray (Australian Genome Research Facility, Melbourne, Victoria, Australia).
A subset of 7353 highly informative SNPs were chosen for linkage mapping across the 22 autosomal chromosomes (Appendix S1, Methods). To account for the exceptionally large pedigree, we employed an approximate nonparametric linkage analysis with MORGAN using the lm_ibdtests option. Three analyses, with different starting points, were run for each chromosome consisting of 10 000 burn-in and 100 000 Monte Carlo iterations. 9 Final P values for the S robdom test statistic were averaged across the three runs. The complete set of genotyped SNPs on chromosome 5 were analyzed to verify the linkage breakpoint coordinates. This also enabled the SNP data for the two putative phenocopies to be interrogated for smaller identity-by-descent or homozygosity-by-descent regions of the shared chromosomal segment that may have gone undetected by the subset of SNPs used in the linkage analysis.
Copy number variant and whole exome sequencing analyses were subsequently performed (Appendix S1, Methods).
| RESULTS
| Clinical presentation
Fourteen family members with seizures and generalized epileptiform discharges on EEG (six male, eight female) were initially evaluated. The mean age of seizure onset was 12 years (range = 6-19 years), with all affected family members reporting fairly homogenous GGE characteristics ( Table 1 ). The familial phenotype most closely resembled JME. Neurological examination and magnetic resonance imaging of the brain were normal in all.
The family was identified through the proband (Figure 1 , VII-10), who had seizure onset at 12 years with frequent episodes of eyelid blinking and brief absences, sometimes associated with myoclonic limb jerking, and in some instances evolving into generalized tonic-clonic seizures (GTCS) on awakening or soon after falling asleep. Seizures were precipitated by sleep deprivation, fatigue, and medication noncompliance. He had no GTCS from 17 to 22 years of age on valproate and levetiracetam but showed rare eyelid blinking episodes with sleep deprivation. He had two additional GTCS associated with medication noncompliance when he was 23 years old. His EEG showed generalized polyspike-and-wave discharges that were not associated with photoparoxysmal responses or eye closure abnormalities ( Figure S1 ); an absence seizure was recorded during hyperventilation at 16 years.
Overall, affected family members presented with a similar electroclinical history, and the prognosis was favorable (Appendix S1, Results). Four of 14 individuals had an earlier onset of seizures but were otherwise indistinguishable from other family members (Table 1) . Of note, individual VII-15 had seizure onset at 19 years with GTCS on awakening; isolated absences and myoclonus were denied. She also had the diagnosis of facioscapulohumeral muscular dystrophy. 
T A B L
E 1 Clinical summary of family members with generalized epileptiform activity on EEG who were included in the linkage
F I G U R E 1 Family pedigree detailing complex inbreeding loops and segregation of the three versions of the chromosome 5 ancestral
haplotype present in either identity-by-descent or homozygosity-by-descent segments. SNP, single nucleotide polymorphism; WES, whole exome sequencing Two additional family members (VI-8, VII-9) were clinically affected, but insufficient information was available (Appendix S1, Results); they were excluded from genetic analyses.
| Genetic analyses
Nonparametric linkage analysis revealed a single region of approximately 39.5 Mb at chromosome 5p13.2-q13.3 (P < 0.0001; Figure S2 ), where 12 affected family members and a single unaffected family member shared one or two copies of the putative disease haplotype (a; Figure 1) . Two affected individuals (VII-1 and VII-15) did not inherit this 5p13.2-q13.3-linked region (haplotype a) and were considered likely phenocopies.
To determine the exact start and end coordinates for the 5p13.2-q13.3 haplotype, we manually examined the complete set of genotyped SNPs shared by affected family members, including the two putative phenocopies, across the region. This process revealed two smaller identity-by-descent segments of the same ancestral haplotype within the pedigree (5p13.2-q11.1 and 5p12-q11.1; Figure S3 ), one of which was present in VII-1. The 5p13.2-q11.1 haplotype (b) was inherited by VII-1 from her father, who was reported to be unaffected (VI-2; Figure 1 ). Further questioning of VI-2 revealed a history of rare myoclonus from age 16 years, and a subsequent EEG demonstrated brief generalized spike and waves, confidently refining the region of interest to 5p13.2-q11.1.
The 5p13.2-q11.1 locus encompasses 15.4 Mb of the genomic region and harbors 114 genes including HCN1, which has been previously associated with epilepsy. 10 The alternate 5p12-q11.1 haplotype (c) of 5.5 Mb encompasses only three genes, again including HCN1 ( Figure S3 ). We cannot, however, confidently limit the region of interest to this segment, as no affected individual carries this smallest version of the putative disease haplotype alone (Figure 1 ). Heterozygous carrier VI-10 had a normal 3-hour EEG examination and was clinically unaffected on close questioning. Penetrance for the refined 5p13.2-q11.1 region (Figure 1 ; haplotypes a and b) is 93%, with one unaffected homozygous carrier (VI-5; Figure 1 ). The homozygous versus heterozygous state for the haplotype was not associated with phenotypic severity or age at seizure onset (Table 1) . Affected family member VII-15 remains unlinked to the chromosome 5 region.
No plausible disease-causing variants were identified (Appendix S1, Results).
| DISCUSSION
The present study describes the electroclinical features of a large consanguineous family from southeastern Turkey with GGE and significant linkage to chromosome 5p13.2-q11.1. Importantly, we define three versions of the same chromosome 5 haplotype that have derived from a common ancestor, have been refined by different recombination events through the generations, and have been brought together in this nuclear family through complex inbreeding (Figure 1 and Figure S3 ). The seizure semiology reported by affected family members was most consistent with JME. As GGE usually follows a complex pattern of inheritance, most families with JME do not show Mendelian transmission 11 ; however, rare autosomal dominant families have been reported, 5 and the possibility of recessive families has been raised. 12 Although JME is characterized by adolescent onset, myoclonic jerks on awakening, accompanied by GTCS in 80%-95% of patients, and in one-third of patients by typical absence seizures, its diagnostic boundaries are not rigidly defined. 13 The phenotype in this family was fairly homogeneous; however, age of onset was relatively broad, with four individuals having early onset. Although >75% of patients with JME have their first seizures between the ages of 12 and 18 years with a mean age at onset of approximately 14 years, 11 this observation is consistent with previous reports of early onset JME syndrome before age 10 years. 14 The four individuals with early onset of seizures had no photoparoxysmal response or eye-closure abnormalities in their EEGs, nor was early onset associated with a particular clinical presentation or prognosis. Linkage analysis in a common condition such as epilepsy can be challenging due to incomplete penetrance and phenocopies. The presence of the putative disease haplotype in individual VI-5, who is still asymptomatic at age 50 years, suggests that the penetrance is high but incomplete in this family. There was also one affected individual (VII-15) who did not link to the chromosome 5 region. The clinical phenotype for VII-15 was somewhat distinguishable from other family members, with late seizure onset at 19 years with GTCS alone (Table 1) .
All other affected family members were shown to share either one or two copies of the refined 5p13.2-q11.1 haplotype, likely reflecting that inbreeding can enrich for disease alleles from common ancestors, leading to a higher penetrance than expected for a dominant disorder. Our results also indicate that mutations in the heterozygous versus homozygous state may result in similar phenotypes. Although this has been reported before, for example in Huntington disease, 15 it is a novel concept for epilepsy genetics.
Alternatively, it may be that this interesting observation is consistent with complex inheritance and the chromosome 5 haplotype is harboring a risk as opposed to a dominant allele. Although the large number of affected family members is suggestive of a Mendelian disorder, the multiple consanguineous unions (leading to a less diverse genetic background) may instead have been ripe for a complex genetic disorder to mimic as Mendelian. The phenocopy e128 | (VII-15) may therefore still be sharing some risk alleles with the nuclear family, but not all (ie, the chromosome 5 allele).
One promising gene located within the chromosome 5 haplotype has been previously associated with epilepsy. Heterozygous mutations in HCN1 can cause early infantile epileptic encephalopathy. 10 This gene quickly became our top candidate, particularly as an excess in ultrarare variation in genes known to cause severe epilepsies has been recently associated with familial GGE. 2 Although we have confidently excluded protein-coding mutations in HCN1, future investigations should focus on noncoding regions. The genetic basis to the GGEs remains elusive. Whereas next generation sequencing has revolutionized genetic research, particularly in monogenic disorders, progress in common complex diseases has been slower. Here, having excluded protein-coding variants in genes and copy number variants previously associated with GGE, we argue that large pedigrees remain valuable in the quest for novel gene discovery. With the search space narrowed to a single region of high significance on chromosome 5, we can target future efforts with confidence.
